Lara Silvana Boerenkamp

Mrs. Lara Silvana Boerenkamp

Maastricht University, Maastricht, Limburg, The Netherlands
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2022 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
FHFloor C.J.I. Heubel-Moenen
Floor C.J.I. Heubel-Moenen
SBSanne L. N. Brouns
Sanne L. N. Brouns
LHLinda Herfs
Linda Herfs
LBLara Silvana Boerenkamp
Lara Silvana Boerenkamp
NJNatalie Jooss
Natalie Jooss
YHYvonne M. C. Henskens
Yvonne M. C. Henskens
Summary: Patients referred for evaluation of bleeding symptoms occasionally have a prolonged platelet function analyser (PFA) closure time, without evidence for von Willebrand disease or impaired platelet aggregation. The aim of this study was to establish a shear‐dependent platelet function defect in these patients. Patients were included based on high bleeding score and prior PFA prolongation. Common tests of von Willebrand factor (VWF) and platelet function and exome sequencing were performed. Microfluidic analysis of shear‐dependent collagen‐induced whole‐blood thrombus formation was performed. In 14 PFA‐only patients, compared to healthy volunteers, microfluidic tests showed significantly lower platelet adhesion and thrombus formation parameters. This was accompanied by lower integrin activation, phosphatidylserine exposure and P‐selectin expression. Principal components analysis indicated VWF as primary explaining variable of PFA prolongation, whereas conventional platelet aggregation primarily explained the reduced thrombus parameters under shear. In five patients with severe microfluidic abnormalities, conventional platelet aggregation was in the lowest range of normal. No causal variants in Mendelian genes known to cause bleeding or platelet disorders were identified. Multiparameter assessment of whole‐blood thrombus formation under shear indicates single or combined effects of low–normal VWF and low–normal platelet aggregation in these patients, suggesting a shear‐dependent platelet function defect, not detected by static conventional haemostatic tests.

11 November 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
GGGwendolyn N.Y. Van Gorkom
Gwendolyn N.Y. Van Gorkom
LBLara Silvana Boerenkamp
Lara Silvana Boerenkamp
BGBirgit L. M. G. Gijsbers
Birgit L. M. G. Gijsbers
HOHeidi H. van Ojik
Heidi H. van Ojik
WWWill K. W. H. Wodzig
Will K. W. H. Wodzig
Gerard BosGerard Bos
Gerard Bos
Vitamin C is an important micronutrient for various immune cells. It increases phagocytic cell function and is necessary for T and natural killer (NK) cell development. Patients in need of an autologous hematopoietic stem cell transplantation (HSCT) are often vitamin C-depleted. We therefore hypothesized that vitamin C supplementation could improve immune recovery in autologous HSCT patients. This blinded, placebo-controlled trial included 44 patients randomized to receive vitamin C or a placebo. The following outcome measures used were clinical and immunological parameters, among others: time to neutrophil recovery, serum, and intracellular vitamin C values. Twenty-one patients received vitamin C, and 23 received a placebo. The time to neutrophil recovery did not differ between the two groups at 11.2 days (p = 0.96). There were no differences in hospitalization time (19.7 vs. 19.1 days, p = 0.80), the incidence of neutropenic fever (57% vs. 78%, p = 0.20), or 3-month overall survival (90.5% vs. 100%, p = 0.13). Bacteremia seemed to occur less in the vitamin C group (10% vs. 35%, p = 0.07). Our study shows no benefit from vitamin C supplementation on neutrophil recovery and hospitalization, despite possible lower rates of bacteremia in the vitamin C group. Therefore, we do not advise vitamin C supplementation in this treatment group.

24 September 2022 in American Journal of Hematology
Verified
Journal Article
Closed access
LBLara Silvana Boerenkamp
Lara Silvana Boerenkamp
CPCilia R. Pothast
Cilia R. Pothast
RDRomy C. Dijkland
Romy C. Dijkland
KDKayleigh van Dijk
Kayleigh van Dijk
GGGwendolyn N. Y. van Gorkom
Gwendolyn N. Y. van Gorkom
CECatharina Van Elssen
Catharina Van Elssen

20 August 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
LBLara Silvana Boerenkamp
Lara Silvana Boerenkamp
BGBirgit L. M. G. Gijsbers
Birgit L. M. G. Gijsbers
EVErik-Jan Ververs
Erik-Jan Ververs
EPEva M. S. Pijpers
Eva M. S. Pijpers
BSBart Spaetgens
Bart Spaetgens
CECatharina Van Elssen
Catharina Van Elssen
Vitamin C is a crucial micronutrient for human immune cell function and has potent antioxidant properties. It is hypothesized that vitamin C serum levels decline during infection. However, the precise mechanisms remain unknown. To gain deeper insights into the true role of vitamin C during infections, we aimed to evaluate the body’s vitamin C storage during a SARS-CoV-2 infection. In this single-center study, we examined serum and intracellular vitamin C levels in peripheral blood mononuclear cells (PBMCs) of 70 hospitalized COVID-19 patients on the first and fifth days of hospitalization. Also, clinical COVID-19 severity was evaluated at these timepoints. Our findings revealed a high prevalence of hypovitaminosis C and vitamin C deficiency in hospitalized COVID-19 patients (36% and 15%). Moreover, patients with severe or critical disease exhibited a higher prevalence of low serum vitamin C levels than those with moderate illness. Serum vitamin C levels had a weak negative correlation with clinical COVID-19 severity classification on the day of hospitalization; however, there was no correlation with intracellular vitamin C. Intracellular vitamin C levels were decreased in this cohort as compared to a healthy cohort and showed further decline during hospitalization, while serum levels showed no relevant change. Based on this observation, it can be suggested that the reduction of intracellular vitamin C may be attributed to its antioxidative function, the need for replenishing serum levels, or enhanced turnover by immune cells. These data give an incentive to further investigate the role of intracellular vitamin C in a larger and more heterogeneous cohort as well as the underlying mechanisms.

23 June 2022 in HemaSphere
Verified
Journal Article
Open access
LBLara Silvana Boerenkamp
Lara Silvana Boerenkamp
CPC. R. Pothast
C. R. Pothast
RDR. C. Dijkland
R. C. Dijkland
ILI. H. van Loo
I. H. van Loo
LWL. Wieten
L. Wieten
CEC. H. Van Elssen
C. H. Van Elssen

30 October 2026 in European Journal of Haematology
Verified
Journal Article
Open access
PDF file
LBLara Silvana Boerenkamp
Lara Silvana Boerenkamp
NSN. Scheffers
N. Scheffers
LBL. Brandts
L. Brandts
GGGwendolyn N.Y. Van Gorkom
Gwendolyn N.Y. Van Gorkom
CPC. R. Pothast
C. R. Pothast
CECatharina Van Elssen
Catharina Van Elssen
Patients with hematologic malignancies (HM) often mount poor humoral responses to SARS‐CoV‐2 vaccination due to their immunocompromised status. Protection against severe COVID‐19 is strongly related to cellular immunity, yet vaccine‐induced T‐cell responses remain incompletely characterized. We conducted a systematic review of 87 studies assessing vaccine‐induced T‐cell response rates in HM. Across HM subtypes, 75%–87% of studies reported T‐cell response rates of at least 50%. Active disease was associated with reduced T‐cell responses. These findings indicate that SARS‐CoV‐2 vaccination can elicit cellular immunity in HM patients, including those receiving immunosuppressive therapy, supporting continued vaccination strategies even when humoral responses are suboptimal.